Categories
CoronaVirus News

COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says By Reuters – Investing.com


COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says By Reuters  Investing.com